This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ARCA biopharma Inc (ABIO)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 15.35M 16.76M 2.92M 5.94M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 134.00K 169.00K 125.00K 269.00K
Total Current Assets 15.49M 16.92M 3.04M 6.21M
Property, Plant & Equipment, Gross 418.00K 514.00K 533.00K 533.00K
Accumulated Depreciation & Depletion 382.00K 485.00K 510.00K 467.00K
Property, Plant & Equipment, Net 36.00K 29.00K 23.00K 66.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 608.00K 130.00K 144.00K 224.00K
Total Non-Current Assets 644.00K 159.00K 167.00K 290.00K
Liabilities & Shareholder Equity
Total Assets 16.13M 17.08M 3.21M 6.50M
Accounts Payable 795.00K 597.00K 65.00K 260.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 1.39M 1.50M 305.00K 754.00K
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 3.00K 1.00K 0.00 16.00K
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 3.00K 1.00K 0.00 16.00K
Total Liabilities 1.39M 1.50M 305.00K 770.00K
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 14.74M 15.58M 2.91M 5.73M
Common Par 21.00K 16.00K 3.00K 12.00K
Additional Paid In Capital 99.34M 90.50M 70.90M 69.39M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -84.62M -74.93M -67.99M -63.67M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 14.74M 15.58M 2.91M 5.73M
Total Equity 14.74M 15.58M 2.91M 5.73M
Total Liabilities & Stock Equity 16.13M 17.08M 3.21M 6.50M
Total Common Shares Outstanding 21.15M 15.69M 2.66M 2.03M
Preferred Shares 24.90K 24.90K 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 20.50M 8.63M 2.22M 1.67M
Diluted Weighted Shares Outstanding 20.50M 8.63M 2.22M 1.67M
Number of Employees 16 14 6 11
Number of Part-Time Employees 0 0 5 3
ABIO News

ABIO ARCA biopharma Inc

Chart of ABIO

Analysts Ratings for ABIO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ABIO ANALYST REPORT

Brokerage Partners

ABIO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs